| Line |
Label |
Object Class |
Period Type |
Balance |
Report ElementName |
| 1 |
00000001 - Document - Document and Entity Information |
Network |
* |
* |
http://enterabio.com/role/DocumentAndEntityInformation |
| 2 |
Implied Table |
Table |
* |
* |
implied:Table |
| 3 |
Document And Entity Information |
Abstract |
|
|
entx:DocumentAndEntityInformationAbstract |
| 4 |
Entity Registrant Name |
Concept (Text/String) |
For Period |
|
dei:EntityRegistrantName |
| 5 |
Entity Central Index Key |
Concept (CIK Number) |
For Period |
|
dei:EntityCentralIndexKey |
| 6 |
Document Type |
Concept (Submission Type) |
For Period |
|
dei:DocumentType |
| 7 |
Document Period End Date |
Concept (Date) |
For Period |
|
dei:DocumentPeriodEndDate |
| 8 |
Amendment Flag |
Concept (Yes/No) |
For Period |
|
dei:AmendmentFlag |
| 9 |
Current Fiscal Year End Date |
Concept (Month/Day) |
For Period |
|
dei:CurrentFiscalYearEndDate |
| 10 |
Is Entity a Well-known Seasoned Issuer? |
Concept (Yes/No) |
For Period |
|
dei:EntityWellKnownSeasonedIssuer |
| 11 |
Is Entity a Voluntary Filer? |
Concept (Yes/No) |
For Period |
|
dei:EntityVoluntaryFilers |
| 12 |
Is Entity's Reporting Status Current? |
Concept (Yes/No) |
For Period |
|
dei:EntityCurrentReportingStatus |
| 13 |
Entity Filer Category |
Concept (Filer Category) |
For Period |
|
dei:EntityFilerCategory |
| 14 |
Entity Shell Company |
Concept (Yes/No) |
For Period |
|
dei:EntityShellCompany |
| 15 |
Entity Emerging Growth Company |
Concept (Yes/No) |
For Period |
|
dei:EntityEmergingGrowthCompany |
| 16 |
Entity Transition Period |
Concept (Yes/No) |
For Period |
|
dei:EntityExTransitionPeriod |
| 17 |
Entity Public Float |
Concept (Monetary) |
As Of |
Credit |
dei:EntityPublicFloat |
| 18 |
Entity Common Stock, Shares Outstanding |
Concept (Shares) |
As Of |
|
dei:EntityCommonStockSharesOutstanding |
| 19 |
Document Fiscal Period Focus |
Concept (Fiscal Period) |
For Period |
|
dei:DocumentFiscalPeriodFocus |
| 20 |
Document Fiscal Year Focus |
Concept (Year) |
For Period |
|
dei:DocumentFiscalYearFocus |
| 21 |
00000002 - Statement - CONSOLIDATED STATEMENTS OF FINANCIAL POSITION |
Network |
* |
* |
http://enterabio.com/role/ConsolidatedStatementsOfFinancialPosition |
| 22 |
Implied Table |
Table |
* |
* |
implied:Table |
| 23 |
Statement of financial position [abstract] |
Abstract |
|
|
ifrs-full:StatementOfFinancialPositionAbstract |
| 24 |
Assets |
Abstract |
|
|
ifrs-full:AssetsAbstract |
| 25 |
CURRENT ASSETS: |
Abstract |
|
|
ifrs-full:CurrentAssetsAbstract |
| 26 |
Cash and cash equivalents |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
| 27 |
Short-term bank deposits |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents |
| 28 |
Accounts receivable |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:TradeAndOtherCurrentReceivables |
| 29 |
Other current assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:OtherCurrentFinancialAssets |
| 30 |
TOTAL CURRENT ASSETS |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentAssets |
| 31 |
NON-CURRENT ASSETS: |
Abstract |
|
|
ifrs-full:NoncurrentAssetsAbstract |
| 32 |
Property and equipment |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:PropertyPlantAndEquipment |
| 33 |
Intangible assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:IntangibleAssetsOtherThanGoodwill |
| 34 |
TOTAL NON-CURRENT ASSETS |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:NoncurrentAssets |
| 35 |
TOTAL ASSETS |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Assets |
| 36 |
Liabilities and shareholders' equity (net of capital deficiency) |
Abstract |
|
|
ifrs-full:EquityAndLiabilitiesAbstract |
| 37 |
CURRENT LIABILITIES: |
Abstract |
|
|
ifrs-full:CurrentLiabilitiesAbstract |
| 38 |
Accounts payable: |
Abstract |
|
|
ifrs-full:TradeAndOtherCurrentPayablesAbstract |
| 39 |
Trade |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers |
| 40 |
Other |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:TradeAndOtherCurrentPayables |
| 41 |
Contract liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentContractLiabilities |
| 42 |
TOTAL CURRENT LIABILITIES |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentLiabilities |
| 43 |
NON-CURRENT LIABILITIES: |
Abstract |
|
|
ifrs-full:NoncurrentLiabilitiesAbstract |
| 44 |
Convertible loan |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:LongtermBorrowings |
| 45 |
Preferred shares |
Concept (Monetary) |
As Of |
Credit |
entx:PreferredSharesValue |
| 46 |
Warrants to purchase ordinary shares and preferred shares |
Concept (Monetary) |
As Of |
Credit |
entx:WarrantsToPurchaseOrdinarySharesAndPreferredShares |
| 47 |
Liability to issue preferred shares and warrants |
Concept (Monetary) |
As Of |
Credit |
entx:LiabilityToIssuePreferredSharesAndWarrants |
| 48 |
Severance pay obligations, net |
Concept (Monetary) |
As Of |
Credit |
entx:SeverancePayObligationsNet |
| 49 |
TOTAL NON-CURRENT LIABILITIES |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:NoncurrentLiabilities |
| 50 |
TOTAL LIABILITIES |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Liabilities |
| 51 |
COMMITMENTS AND CONTINGENCIES |
Concept (Monetary) |
As Of |
Credit |
entx:CommitmentAndContingencies |
| 52 |
SHAREHOLDERS' EQUITY (CAPITAL DEFICIENCY): |
Abstract |
|
|
ifrs-full:EquityAbstract |
| 53 |
Ordinary Shares, NIS 0.0000769 par value: Authorized - as of December 31, 2018 and December 31, 2017, 140,010,000 and 130,000,000 shares, respectively; issued and outstanding: as of December 31, 2018, and December 31, 2017-11,459,780 and 4,490,720 shares, respectively |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:IssuedCapital |
| 54 |
Accumulated other comprehensive income |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:AccumulatedOtherComprehensiveIncome |
| 55 |
Other reserves |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:OtherReserves |
| 56 |
Additional paid in capital |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:AdditionalPaidinCapital |
| 57 |
Accumulated deficit |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:RetainedEarnings |
| 58 |
TOTAL SHAREHOLDERS' EQUITY (CAPITAL DEFICIENCY) |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Equity |
| 59 |
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY (NET OF CAPITAL DEFICIENCY) |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:EquityAndLiabilities |
| 60 |
00000003 - Statement - CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Parenthetical) |
Network |
* |
* |
http://enterabio.com/role/StatementsOfFinancialPositionParenthetical |
| 61 |
Implied Table |
Table |
* |
* |
implied:Table |
| 62 |
Statement of financial position [abstract] |
Abstract |
|
|
ifrs-full:StatementOfFinancialPositionAbstract |
| 63 |
Ordinary Shares, par value |
Concept (Share) |
As Of |
|
ifrs-full:ParValuePerShare |
| 64 |
Ordinary Shares, Authorized |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesAuthorised |
| 65 |
Ordinary Shares, Issued |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesIssued |
| 66 |
Ordinary Shares, Outstanding |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesOutstanding |
| 67 |
00000004 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS |
Network |
* |
* |
http://enterabio.com/role/ConsolidatedStatementsOfComprehensiveLoss |
| 68 |
Implied Table |
Table |
* |
* |
implied:Table |
| 69 |
Profit or loss [abstract] |
Abstract |
|
|
ifrs-full:IncomeStatementAbstract |
| 70 |
REVENUE |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:Revenue |
| 71 |
RESEARCH AND DEVELOPMENT EXPENSES, NET |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ResearchAndDevelopmentExpense |
| 72 |
GENERAL AND ADMINISTRATIVE EXPENSES |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:GeneralAndAdministrativeExpense |
| 73 |
OPERATING LOSS |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossFromOperatingActivities |
| 74 |
FINANCIAL INCOME: |
Abstract |
|
|
entx:FinancialIncomeAbstract |
| 75 |
Income from change in fair value of financial liabilities at fair value through profit or loss |
Concept (Monetary) |
For Period |
Credit |
entx:IncomeFromChangeInFairValueOfFinancialLiabilitiesAtFairValueThroughProfitAndLoss |
| 76 |
Other financial expenses (income), net |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:OtherFinanceCost |
| 77 |
FINANCIAL INCOME, net |
Concept (Monetary) |
For Period |
Debit |
entx:FinancialExpensesIncomeNet |
| 78 |
NET COMPREHENSIVE LOSS |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLoss |
| 79 |
LOSS PER ORDINARY SHARE - |
Abstract |
|
|
ifrs-full:EarningsPerShareAbstract |
| 80 |
Basic |
Concept (Share) |
For Period |
|
ifrs-full:BasicEarningsLossPerShare |
| 81 |
Diluted |
Concept (Share) |
For Period |
|
ifrs-full:DilutedEarningsLossPerShare |
| 82 |
WEIGHTED AVERAGE NUMBER OF ORDINARY SHARES - |
Abstract |
|
|
ifrs-full:WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract |
| 83 |
Basic |
Concept (Shares) |
For Period |
|
ifrs-full:WeightedAverageShares |
| 84 |
Diluted |
Concept (Shares) |
For Period |
|
ifrs-full:AdjustedWeightedAverageShares |
| 85 |
00000005 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDER'S EQUITY (CHANGES IN CAPITAL DEFICIENCY) |
Network |
* |
* |
http://enterabio.com/role/ConsolidatedStatementsOfShareholdersEquityChangesInCapitalDeficiency |
| 86 |
Statement of changes in equity [table] |
Table |
* |
* |
ifrs-full:StatementOfChangesInEquityTable |
| 87 |
Components of equity [axis] |
Axis |
|
|
ifrs-full:ComponentsOfEquityAxis |
| 88 |
Equity [member] |
Member |
|
|
ifrs-full:EquityMember |
| 89 |
Number of ordinary shares [Member] |
Member |
|
|
ifrs-full:IssuedCapitalMember |
| 90 |
Accumulated other comprehensive income [Member] |
Member |
|
|
ifrs-full:AccumulatedOtherComprehensiveIncomeMember |
| 91 |
Other reserves [Member] |
Member |
|
|
ifrs-full:OtherReservesMember |
| 92 |
Additional paid in capital [Member] |
Member |
|
|
ifrs-full:AdditionalPaidinCapitalMember |
| 93 |
Accumulated deficit [Member] |
Member |
|
|
ifrs-full:RetainedEarningsMember |
| 94 |
Statement of changes in equity [line items] |
LineItems |
|
|
ifrs-full:StatementOfChangesInEquityLineItems |
| 95 |
BALANCE |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Equity |
| 96 |
BALANCE, shares |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesOutstanding |
| 97 |
CHANGES DURING THE YEAR ENDED DECEMBER 31 |
Abstract |
|
|
ifrs-full:ChangesInEquityAbstract |
| 98 |
Issuance of shares |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IssueOfEquity |
| 99 |
Issuance of shares, shares |
Concept (Shares) |
For Period |
|
entx:IssueOfEquityShares |
| 100 |
Loss for the year |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLoss |
| 101 |
Share-based compensation |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForSharebasedPayments |
| 102 |
Issuance of shares and warrants, net |
Concept (Monetary) |
For Period |
Credit |
entx:IssuanceOfSharesAndWarrantsNet |
| 103 |
Issuance of shares and warrants, net, shares |
Concept (Shares) |
For Period |
|
entx:IssuanceOfSharesAndWarrantsNetShares |
| 104 |
Conversion of Preferred shares into Ordinary shares |
Concept (Monetary) |
For Period |
Credit |
entx:ConversionOfPreferredSharesIntoOrdinaryShares |
| 105 |
Conversion of Preferred shares into Ordinary shares, shares |
Concept (Shares) |
For Period |
|
entx:ConversionOfPreferredSharesIntoOrdinarySharesInShares |
| 106 |
Conversion of convertible loan into Ordinary shares |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments |
| 107 |
Conversion of convertible loan into Ordinary shares, shares |
Concept (Shares) |
For Period |
|
entx:IncreaseDecreaseThroughConversionOfConvertibleInstrumentsShares |
| 108 |
Classification of Warrants to purchase preferred shares and shares into Warrants to purchase ordinary shares |
Concept (Monetary) |
For Period |
Credit |
entx:ConversionOfWarrantsToPurchasePreferredSharesAndSharesIntoWarrantsToPurchaseOrdinarySharesAndShares |
| 109 |
Reclassification due to share-based compensation expired |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions |
| 110 |
Exercise of option to ordinary shares |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughExerciseOfOptions |
| 111 |
Exercise of option to ordinary shares, shares |
Concept (Shares) |
For Period |
|
entx:IncreaseDecreaseThroughExerciseOfWarrantsEquityShares |
| 112 |
Reclassification of capital contribution from controlling shareholder (note 7a) |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners |
| 113 |
BALANCE |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Equity |
| 114 |
BALANCE, shares |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesOutstanding |
| 115 |
00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS |
Network |
* |
* |
http://enterabio.com/role/ConsolidatedStatementsOfCashFlows |
| 116 |
Implied Table |
Table |
* |
* |
implied:Table |
| 117 |
Statement of cash flows [abstract] |
Abstract |
|
|
ifrs-full:StatementOfCashFlowsAbstract |
| 118 |
CASH FLOWS USED IN OPERATING ACTIVITIES: |
Abstract |
|
|
ifrs-full:CashFlowsFromUsedInOperatingActivitiesAbstract |
| 119 |
Loss for the year |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLoss |
| 120 |
Adjustments required to reflect net cash used in operating activities (see appendix A) |
Concept (Monetary) |
For Period |
|
ifrs-full:CashFlowsFromUsedInOperations |
| 121 |
Net cash used in operating activities |
Concept (Monetary) |
For Period |
|
ifrs-full:CashFlowsFromUsedInOperatingActivities |
| 122 |
CASH FLOWS PROVIDED BY (USED IN) INVESTING ACTIVITIES: |
Abstract |
|
|
ifrs-full:CashFlowsFromUsedInInvestingActivitiesAbstract |
| 123 |
Decrease (increase) in restricted deposits |
Concept (Monetary) |
For Period |
Debit |
entx:CashFlowsFromUsedInDecreaseIncreaseInRestrictedDeposits |
| 124 |
Purchase of short-term bank deposits |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForIncreaseDecreaseInDepositsFromBanks |
| 125 |
Purchase of property and equipment |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| 126 |
Net cash provided by (used in) investing activities |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CashFlowsFromUsedInInvestingActivities |
| 127 |
CASH FLOWS PROVIDED BY FINANCING ACTIVITIES: |
Abstract |
|
|
ifrs-full:CashFlowsFromUsedInFinancingActivitiesAbstract |
| 128 |
Issuance of ordinary shares and tradable warrants, net of issuance costs |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromIssueOfOrdinaryShares |
| 129 |
Proceeds from convertible loan and warrants, net |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities |
| 130 |
Proceeds from issuance of preferred shares and warrants, net |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromIssuingShares |
| 131 |
Payment for maturity of Convertible loans |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities |
| 132 |
Net cash generated from financing activities |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CashFlowsFromUsedInFinancingActivities |
| 133 |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncreaseDecreaseInCashAndCashEquivalents |
| 134 |
CASH AND CASH EQUIVALENTS AT BEGINNING OF THE YEAR |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
| 135 |
CASH AND CASH EQUIVALENTS AT END OF THE YEAR |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
| 136 |
Adjustments required to reflect net cash used in operating activities: |
Abstract |
|
|
entx:AdjustmentsRequiredToReflectNetCashUsedInOperatingActivitiesAbstract |
| 137 |
Depreciation and amortization |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:DepreciationAndAmortisationExpense |
| 138 |
Income from change in fair value of financial liabilities at fair value through profit or loss |
Concept (Monetary) |
For Period |
Credit |
entx:IncomeFromChangeInFairValueOfFinancialLiabilitiesAtFairValueThroughProfitAndLoss |
| 139 |
Issuance costs |
Concept (Monetary) |
For Period |
Debit |
entx:AdjustmentsForIssuanceCostsRelatedToOrdinarySharesPreferredSharesConvertibleLoanAndWarrants |
| 140 |
Financial expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForFinanceCosts |
| 141 |
Net changes in severance pay obligation |
Concept (Monetary) |
For Period |
Debit |
entx:AdjustmentsForNetChangesInSeverancePay |
| 142 |
Share-based compensation |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForSharebasedPayments |
| 143 |
Total adjustments |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForReconcileProfitLoss |
| 144 |
Changes in working capital: |
Abstract |
|
|
entx:ChangesInWorkingCapitalAbstract |
| 145 |
Decrease (increase) in other current assets |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets |
| 146 |
(Increase) decrease in accounts receivable |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable |
| 147 |
Increase (decrease) in accounts payable: |
Abstract |
|
|
entx:IncreaseDecreasesInAccountsPayableAbstract |
| 148 |
Trade |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable |
| 149 |
Other |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForIncreaseDecreaseInOtherOperatingPayables |
| 150 |
Increase in contract liabilities |
Concept (Monetary) |
For Period |
Debit |
entx:AdjustmentsForIncreaseDecreaseInContractLiabilities |
| 151 |
Changes in working capital |
Concept (Monetary) |
For Period |
Debit |
entx:AdjustmentsForChangesInWorkingCapital |
| 152 |
Cash used for operating activities - |
Abstract |
|
|
ifrs-full:AdjustmentsForReconcileProfitLossAbstract |
| 153 |
Interest paid |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:InterestPaidClassifiedAsOperatingActivities |
| 154 |
Cash used for operating activities |
Concept (Monetary) |
For Period |
|
ifrs-full:CashFlowsFromUsedInOperations |
| 155 |
Supplementary information on financing activities not involving cash flows: |
Abstract |
|
|
entx:SupplementaryInformationOnFinancingActivitiesNotInvolvingCashFlowsAbstract |
| 156 |
Conversion of preferred shares into ordinary shares |
Concept (Monetary) |
For Period |
Credit |
entx:ConversionOfPreferredSharesIntoOrdinaryShares |
| 157 |
Conversion of convertible loan into ordinary shares |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments |
| 158 |
00000007 - Disclosure - GENERAL INFORMATION |
Network |
* |
* |
http://enterabio.com/role/GeneralInformation |
| 159 |
Implied Table |
Table |
* |
* |
implied:Table |
| 160 |
Disclosure of general information [abstract] |
Abstract |
|
|
entx:DisclosureOfGeneralInformationAbstract |
| 161 |
GENERAL INFORMATION |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory |
| 162 |
00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
Network |
* |
* |
http://enterabio.com/role/SummaryOfSignificantAccountingPolicies |
| 163 |
Implied Table |
Table |
* |
* |
implied:Table |
| 164 |
Disclosure of summary of significant accounting policies [abstract] |
Abstract |
|
|
entx:DisclosureOfSummaryOfSignificantAccountingPoliciesAbstract |
| 165 |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory |
| 166 |
00000009 - Disclosure - CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS |
Network |
* |
* |
http://enterabio.com/role/CriticalAccountingEstimatesAndJudgements |
| 167 |
Implied Table |
Table |
* |
* |
implied:Table |
| 168 |
Disclosure of critical accounting estimates and judgements [abstract] |
Abstract |
|
|
entx:DisclosureOfCriticalAccountingEstimatesAndJudgementsAbstract |
| 169 |
CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory |
| 170 |
00000010 - Disclosure - FINANCIAL INSTRUMENTS |
Network |
* |
* |
http://enterabio.com/role/FinancialInstruments |
| 171 |
Implied Table |
Table |
* |
* |
implied:Table |
| 172 |
Disclosure of detailed information about financial instruments [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfFinancialInstrumentsAbstract |
| 173 |
FINANCIAL INSTRUMENTS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfFinancialInstrumentsExplanatory |
| 174 |
00000011 - Disclosure - CASH AND CASH EQUIVALENTS |
Network |
* |
* |
http://enterabio.com/role/CashAndCashEquivalents |
| 175 |
Implied Table |
Table |
* |
* |
implied:Table |
| 176 |
Cash and cash equivalents [abstract] |
Abstract |
|
|
ifrs-full:CashAndCashEquivalentsAbstract |
| 177 |
CASH AND CASH EQUIVALENTS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory |
| 178 |
00000012 - Disclosure - INTANGIBLE ASSETS |
Network |
* |
* |
http://enterabio.com/role/IntangibleAssets |
| 179 |
Implied Table |
Table |
* |
* |
implied:Table |
| 180 |
Disclosure of detailed information about intangible assets [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfIntangibleAssetsAbstract |
| 181 |
INTANGIBLE ASSETS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfIntangibleAssetsExplanatory |
| 182 |
00000013 - Disclosure - CONVERTIBLE LOANS |
Network |
* |
* |
http://enterabio.com/role/ConvertibleLoans |
| 183 |
Implied Table |
Table |
* |
* |
implied:Table |
| 184 |
Disclosure of detailed information about borrowings [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsAbstract |
| 185 |
CONVERTIBLE LOANS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfBorrowingsExplanatory |
| 186 |
00000014 - Disclosure - PREFERRED SHARES AND WARRANTS TO PREFERED SHARES |
Network |
* |
* |
http://enterabio.com/role/PreferredSharesAndWarrantsToPreferedShares |
| 187 |
Implied Table |
Table |
* |
* |
implied:Table |
| 188 |
Disclosure of preferred shares and warrants to prefered shares [abstract] |
Abstract |
|
|
entx:DisclosureOfPreferredSharesAndWarrantsToPreferedSharesAbstract |
| 189 |
PREFERRED SHARES AND WARRANTS TO PREFERED SHARES |
Concept (Text Block (HTML)) |
For Period |
|
entx:DisclosureOfPreferredSharesAndWarrantsToPreferedSharesExplanatory |
| 190 |
00000015 - Disclosure - COMMITMENTS |
Network |
* |
* |
http://enterabio.com/role/Commitments |
| 191 |
Implied Table |
Table |
* |
* |
implied:Table |
| 192 |
Disclosure of contingent liabilities [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfContingentLiabilitiesAbstract |
| 193 |
COMMITMENTS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfCommitmentsExplanatory |
| 194 |
00000016 - Disclosure - SHARE CAPITAL |
Network |
* |
* |
http://enterabio.com/role/ShareCapital |
| 195 |
Implied Table |
Table |
* |
* |
implied:Table |
| 196 |
Disclosure of classes of share capital [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalAbstract |
| 197 |
SHARE CAPITAL |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory |
| 198 |
00000017 - Disclosure - TAXES ON INCOME |
Network |
* |
* |
http://enterabio.com/role/TaxesOnIncome |
| 199 |
Implied Table |
Table |
* |
* |
implied:Table |
| 200 |
Major components of tax expense (income) [abstract] |
Abstract |
|
|
ifrs-full:MajorComponentsOfTaxExpenseIncomeAbstract |
| 201 |
TAXES ON INCOME |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfIncomeTaxExplanatory |
| 202 |
00000018 - Disclosure - REVENUE FROM CONTRACTS WITH CUSTOMERS |
Network |
* |
* |
http://enterabio.com/role/RevenueFromContractsWithCustomers |
| 203 |
Implied Table |
Table |
* |
* |
implied:Table |
| 204 |
Receivables from contracts with customers [abstract] |
Abstract |
|
|
ifrs-full:ReceivablesFromContractsWithCustomersAbstract |
| 205 |
REVENUE FROM CONTRACTS WITH CUSTOMERS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory |
| 206 |
00000019 - Disclosure - SUPPLEMENTARY FINANCIAL INFORMATION |
Network |
* |
* |
http://enterabio.com/role/SupplementaryFinancialInformation |
| 207 |
Implied Table |
Table |
* |
* |
implied:Table |
| 208 |
Disclosure of supplementary financial information [abstract] |
Abstract |
|
|
entx:DisclosureOfSupplementaryFinancialInformationAbstract |
| 209 |
SUPPLEMENTARY FINANCIAL INFORMATION |
Concept (Text Block (HTML)) |
For Period |
|
entx:DisclosureOfSupplementaryFinancialInformationExplanatory |
| 210 |
00000020 - Disclosure - BASIC AND DILUTED LOSS PER SHARE |
Network |
* |
* |
http://enterabio.com/role/BasicAndDilutedLossPerShare |
| 211 |
Implied Table |
Table |
* |
* |
implied:Table |
| 212 |
Basic and diluted earnings per share [abstract] |
Abstract |
|
|
ifrs-full:BasicAndDilutedEarningsPerShareAbstract |
| 213 |
BASIC AND DILUTED LOSS PER SHARE |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfEarningsPerShareExplanatory |
| 214 |
00000021 - Disclosure - RELATED PARTIES - TRANSACTIONS AND BALANCES |
Network |
* |
* |
http://enterabio.com/role/RelatedParties-TransactionsAndBalances |
| 215 |
Implied Table |
Table |
* |
* |
implied:Table |
| 216 |
Disclosure of transactions between related parties [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesAbstract |
| 217 |
RELATED PARTIES - TRANSACTIONS AND BALANCES |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfRelatedPartyExplanatory |
| 218 |
00000022 - Disclosure - SUBSEQUENT EVENTS |
Network |
* |
* |
http://enterabio.com/role/SubsequentEvents |
| 219 |
Implied Table |
Table |
* |
* |
implied:Table |
| 220 |
Disclosure of non-adjusting events after reporting period [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract |
| 221 |
SUBSEQUENT EVENTS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory |
| 222 |
00000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) |
Network |
* |
* |
http://enterabio.com/role/SummaryOfSignificantAccountingPoliciesPolicies |
| 223 |
Implied Table |
Table |
* |
* |
implied:Table |
| 224 |
Disclosure of summary of significant accounting policies [abstract] |
Abstract |
|
|
entx:DisclosureOfSummaryOfSignificantAccountingPoliciesAbstract |
| 225 |
Basis of preparation of the financial statements |
Concept (Text Block (HTML)) |
For Period |
|
entx:DescriptionOfAccountingPolicyForBasisOfPreparationOfFinancialStatementsExplanatory |
| 226 |
Functional and presentation currency |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory |
| 227 |
Basis of consolidation |
Concept (Text Block (HTML)) |
For Period |
|
entx:BasisOfConsolidationPolicyTextBlock |
| 228 |
Cash and cash equivalents |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents |
| 229 |
Short-term bank deposits |
Concept (Text Block (HTML)) |
For Period |
|
entx:DescriptionOfAccountingPolicyForShortTermBankDepositsExplanatory |
| 230 |
Restricted deposits |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory |
| 231 |
Property and equipment |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory |
| 232 |
Intangible assets |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory |
| 233 |
Impairment of non-financial assets |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory |
| 234 |
Segment reporting |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory |
| 235 |
Financial instrument |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory |
| 236 |
Financial Liabilities |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory |
| 237 |
Share capital |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForIssuedCapitalExplanatory |
| 238 |
Deferred income tax |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory |
| 239 |
Share-based payments |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory |
| 240 |
Revenue recognition |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue |
| 241 |
Cost of revenues |
Concept (Text Block (HTML)) |
For Period |
|
entx:DescriptionOfAccountingPolicyForCostOfRevenues |
| 242 |
Government grants |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForGovernmentGrants |
| 243 |
Loss per ordinary share |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory |
| 244 |
Newly issued and recently adopted Accounting Pronouncements |
Concept (Text Block (HTML)) |
For Period |
|
entx:DescriptionOfAccountingPolicyForNewlyIssuedAndRecentlyAdoptedAccountingPronouncements |
| 245 |
New standards, amendments to standards or interpretations |
Concept (Text Block (HTML)) |
For Period |
|
entx:DescriptionOfAccountingPolicyForNewStandardsAmendmentsToStandardsOrInterpretationsExplanatory |
| 246 |
00000024 - Disclosure - FINANCIAL INSTRUMENTS (Tables) |
Network |
* |
* |
http://enterabio.com/role/FinancialInstrumentsTables |
| 247 |
Implied Table |
Table |
* |
* |
implied:Table |
| 248 |
Disclosure of detailed information about financial instruments [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfFinancialInstrumentsAbstract |
| 249 |
Schedule of Classification of Financial Instruments by Groups |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory |
| 250 |
00000025 - Disclosure - CASH AND CASH EQUIVALENTS (Tables) |
Network |
* |
* |
http://enterabio.com/role/CashAndCashEquivalentsTables |
| 251 |
Implied Table |
Table |
* |
* |
implied:Table |
| 252 |
Cash and cash equivalents [abstract] |
Abstract |
|
|
ifrs-full:CashAndCashEquivalentsAbstract |
| 253 |
Schedule of Cash and Cash Equivalents |
Concept (Text Block (HTML)) |
For Period |
|
entx:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory |
| 254 |
00000026 - Disclosure - CONVERTIBLE LOANS (Tables) |
Network |
* |
* |
http://enterabio.com/role/ConvertibleLoansTables |
| 255 |
Implied Table |
Table |
* |
* |
implied:Table |
| 256 |
Disclosure of detailed information about borrowings [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsAbstract |
| 257 |
Schedule of Convertible Components |
Concept (Text Block (HTML)) |
For Period |
|
entx:DisclosureOfDetailedInformationAboutConvertibleComponentsExplanatory |
| 258 |
Schedule of Convertible Loans |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory |
| 259 |
00000027 - Disclosure - PREFERRED SHARES AND WARRANTS TO PREFERED SHARES (Tables) |
Network |
* |
* |
http://enterabio.com/role/PreferredSharesAndWarrantsToPreferedSharesTables |
| 260 |
Implied Table |
Table |
* |
* |
implied:Table |
| 261 |
Disclosure of preferred shares and warrants to prefered shares [abstract] |
Abstract |
|
|
entx:DisclosureOfPreferredSharesAndWarrantsToPreferedSharesAbstract |
| 262 |
Schedule of Movements in Three Components |
Concept (Text Block (HTML)) |
For Period |
|
entx:DisclosureOfDetailedInformationAboutMovementsInThreeComponentsExplanatory |
| 263 |
Schedule of Valuations of Fair Value of Instruments |
Concept (Text Block (HTML)) |
For Period |
|
entx:DisclosureOfDetailedInformationAboutValuationsOfFairValueOfInstrumentsExplanatory |
| 264 |
00000028 - Disclosure - SHARE CAPITAL (Tables) |
Network |
* |
* |
http://enterabio.com/role/ShareCapitalTables |
| 265 |
Implied Table |
Table |
* |
* |
implied:Table |
| 266 |
Disclosure of classes of share capital [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalAbstract |
| 267 |
Schedule of Composition of Ordinary Shares |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory |
| 268 |
Schedule of Weighted Average Assumptions |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory |
| 269 |
Schedule of Changes in Number of Options and Weighted Average Exercise Prices |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory |
| 270 |
Schedule of Information about Exercise Price and Remaining Contractual Life of Outstanding Options |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory |
| 271 |
00000029 - Disclosure - REVENUE FROM CONTRACTS WITH CUSTOMERS (Tables) |
Network |
* |
* |
http://enterabio.com/role/RevenueFromContractsWithCustomersTables |
| 272 |
Implied Table |
Table |
* |
* |
implied:Table |
| 273 |
Receivables from contracts with customers [abstract] |
Abstract |
|
|
ifrs-full:ReceivablesFromContractsWithCustomersAbstract |
| 274 |
Schedule of Revenues |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory |
| 275 |
00000030 - Disclosure - SUPPLEMENTARY FINANCIAL INFORMATION (Tables) |
Network |
* |
* |
http://enterabio.com/role/SupplementaryFinancialInformationTables |
| 276 |
Implied Table |
Table |
* |
* |
implied:Table |
| 277 |
Disclosure of supplementary financial information [abstract] |
Abstract |
|
|
entx:DisclosureOfSupplementaryFinancialInformationAbstract |
| 278 |
Schedule of Other Current Assets |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory |
| 279 |
Schedule of Accounts Payable Other |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory |
| 280 |
00000031 - Disclosure - BASIC AND DILUTED LOSS PER SHARE (Tables) |
Network |
* |
* |
http://enterabio.com/role/BasicAndDilutedLossPerShareTables |
| 281 |
Implied Table |
Table |
* |
* |
implied:Table |
| 282 |
Basic and diluted earnings per share [abstract] |
Abstract |
|
|
ifrs-full:BasicAndDilutedEarningsPerShareAbstract |
| 283 |
Schedule of Basic and Diluted Loss Per Share |
Concept (Text Block (HTML)) |
For Period |
|
entx:DisclosureOfDetailedInformationAboutBasicAndDilutedLossPerShareExplanatory |
| 284 |
00000032 - Disclosure - RELATED PARTIES - TRANSACTIONS AND BALANCES (Tables) |
Network |
* |
* |
http://enterabio.com/role/RelatedParties-TransactionsAndBalancesTables |
| 285 |
Implied Table |
Table |
* |
* |
implied:Table |
| 286 |
Disclosure of transactions between related parties [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesAbstract |
| 287 |
Schedule of Transactions with Related Parties |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory |
| 288 |
Schedule of Balances with Related Parties |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory |
| 289 |
00000033 - Disclosure - GENERAL INFORMATION (Details) |
Network |
* |
* |
http://enterabio.com/role/GeneralInformationDetails |
| 290 |
Statement Table [Table] |
Table |
* |
* |
entx:IfrsStatementTable |
| 291 |
Categories of related parties [axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
| 292 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
| 293 |
Amgen Inc [Member] |
Member |
|
|
entx:AmgenIncMember |
| 294 |
Non-adjusting events after reporting period [Axis] |
Axis |
|
|
ifrs-full:NonadjustingEventsAfterReportingPeriodAxis |
| 295 |
Non-adjusting events after reporting period [member] |
Member |
|
|
ifrs-full:NonadjustingEventsMember |
| 296 |
Amgen Inc [Member] |
Member |
|
|
entx:AmgenIncMember |
| 297 |
Statement Line Items [Line Items] |
LineItems |
|
|
entx:IfrsStatementLineItems |
| 298 |
Accumulated losses |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:RetainedEarnings |
| 299 |
Revenues generated from research collaboration and license agreement |
Concept (Monetary) |
For Period |
Credit |
entx:RevenuesGeneratedFromResearchCollaborationAndLicenseAgreement |
| 300 |
Amount to be paid for preclinical services |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ServicesExpense |
| 301 |
Non-refundable and non-creditable initial technology access fee payment |
Concept (Monetary) |
For Period |
Debit |
entx:NonrefundableAndNoncreditableInitialTechnologyAccessFeePayment |
| 302 |
00000034 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) |
Network |
* |
* |
http://enterabio.com/role/SummaryOfSignificantAccountingPoliciesDetails |
| 303 |
Statement Table [Table] |
Table |
* |
* |
entx:IfrsStatementTable |
| 304 |
Non-adjusting events after reporting period [Axis] |
Axis |
|
|
ifrs-full:NonadjustingEventsAfterReportingPeriodAxis |
| 305 |
Non-adjusting events after reporting period [member] |
Member |
|
|
ifrs-full:NonadjustingEventsMember |
| 306 |
Categories of related parties [axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
| 307 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
| 308 |
Amgen Inc [Member] |
Member |
|
|
entx:AmgenIncMember |
| 309 |
Statement Line Items [Line Items] |
LineItems |
|
|
entx:IfrsStatementLineItems |
| 310 |
Short-term bank deposits annual interest rate |
Concept (Percent) |
For Period |
|
entx:ShorttermBankDepositsAnnualInterestRate |
| 311 |
Initial technology access fee |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:LicenceFeeIncome |
| 312 |
Non-refundable and non-creditable initial technology access fee payment, including payment for the first year of preclinical services |
Concept (Monetary) |
For Period |
Debit |
entx:NonrefundableAndNoncreditableInitialTechnologyAccessFeePayment |
| 313 |
Amount of performance obligations |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations |
| 314 |
Additional amount paid for services to be recognized upon commencement of the pre-clinical Research and Development services |
Concept (Monetary) |
As Of |
Debit |
entx:AdditionalAmountPaidForServicesToBeRecognized |
| 315 |
Revenue from contract with customer |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:Revenue |
| 316 |
Contract liability |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:ContractLiabilities |
| 317 |
Account receivables |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:TradeReceivables |
| 318 |
Increase in Right-of-use assets |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RightofuseAssetsIncreaseDecreaseInRevaluationSurplus |
| 319 |
Discount rate used for measuring lease liability |
Concept (Percent) |
As Of |
|
ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16 |
| 320 |
Government grants as financial liability |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:GovernmentGrants |
| 321 |
Operating lease commitments |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:LeaseCommitmentsForShorttermLeasesForWhichRecognitionExemptionHasBeenUsed |
| 322 |
Right-of-use assets and lease liabilities |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:RightofuseAssets |
| 323 |
Repayment of principal portion of lease liabilities |
Concept (Monetary) |
For Period |
Debit |
entx:RepaymentOfPrincipalPortionOfLeaseLiabilities |
| 324 |
00000035 - Disclosure - FINANCIAL INSTRUMENTS (Schedule of Classification of Financial Instruments by Groups - Assets) (Details) |
Network |
* |
* |
http://enterabio.com/role/FinancialInstrumentsScheduleOfClassificationOfFinancialInstrumentsByGroups-AssetsDetails |
| 325 |
Disclosure of detailed information about financial instruments [table] |
Table |
* |
* |
ifrs-full:DisclosureOfFinancialInstrumentsTable |
| 326 |
Classes of financial instruments [Axis] |
Axis |
|
|
ifrs-full:ClassesOfFinancialInstrumentsAxis |
| 327 |
Financial instruments, class [member] |
Member |
|
|
ifrs-full:ClassesOfFinancialInstrumentsMember |
| 328 |
Financial Instruments [Member] |
Member |
|
|
entx:FinancialInstrumentsMember |
| 329 |
Disclosure of detailed information about financial instruments [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfFinancialInstrumentsLineItems |
| 330 |
Cash and cash equivalents |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
| 331 |
Short-term bank deposits |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents |
| 332 |
Receivables (excluding prepaid expenses) |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:OtherCurrentReceivables |
| 333 |
Financial assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:FinancialAssets |
| 334 |
00000036 - Disclosure - FINANCIAL INSTRUMENTS (Schedule of Classification of Financial Instruments by Groups - Liabilities) (Details) |
Network |
* |
* |
http://enterabio.com/role/FinancialInstrumentsScheduleOfClassificationOfFinancialInstrumentsByGroups-LiabilitiesDetails |
| 335 |
Disclosure of detailed information about financial instruments [table] |
Table |
* |
* |
ifrs-full:DisclosureOfFinancialInstrumentsTable |
| 336 |
Classes of financial liabilities [axis] |
Axis |
|
|
ifrs-full:ClassesOfFinancialLiabilitiesAxis |
| 337 |
Financial liabilities, class [member] |
Member |
|
|
ifrs-full:FinancialLiabilitiesMember |
| 338 |
Financial liabilities at fair value through profit or loss [Member] |
Member |
|
|
ifrs-full:FinancialLiabilitiesAtFairValueMember |
| 339 |
Financial liabilities at amortized cost [Member] |
Member |
|
|
ifrs-full:FinancialLiabilitiesAtAmortisedCostMember |
| 340 |
Categories of financial assets [axis] |
Axis |
|
|
ifrs-full:CategoriesOfFinancialAssetsAxis |
| 341 |
Financial assets, category [member] |
Member |
|
|
ifrs-full:FinancialAssetsCategoryMember |
| 342 |
Disclosure of detailed information about financial instruments [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfFinancialInstrumentsLineItems |
| 343 |
Trade and other payable |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:TradeAndOtherPayables |
| 344 |
Convertible loans (Level 3) |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Borrowings |
| 345 |
Preferred shares (Level 3) |
Concept (Monetary) |
As Of |
Credit |
entx:PreferredSharesValue |
| 346 |
Warrants to purchase ordinary shares |
Concept (Monetary) |
As Of |
Credit |
entx:WarrantsToPurchaseOrdinaryShares |
| 347 |
Warrants to purchase preferred shares and shares (Level 3) |
Concept (Monetary) |
As Of |
Credit |
entx:WarrantsToPurchasePreferredSharesAndShares |
| 348 |
Liability to issue preferred shares and warrants |
Concept (Monetary) |
As Of |
Credit |
entx:LiabilityToIssuePreferredSharesAndWarrants |
| 349 |
Financial liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:FinancialLiabilities |
| 350 |
00000037 - Disclosure - CASH AND CASH EQUIVALENTS (Schedule of Cash and Cash Equivalents) (Details) |
Network |
* |
* |
http://enterabio.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails |
| 351 |
Implied Table |
Table |
* |
* |
implied:Table |
| 352 |
Cash and cash equivalents [abstract] |
Abstract |
|
|
ifrs-full:CashAndCashEquivalentsAbstract |
| 353 |
Cash in bank |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:BalancesWithBanks |
| 354 |
Short-term bank deposits |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents |
| 355 |
Cash and cash equivalents |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
| 356 |
Interest rate on deposits |
Concept (Percent) |
As Of |
|
entx:DepositsInterestRate |
| 357 |
00000038 - Disclosure - INTANGIBLE ASSETS (Details) |
Network |
* |
* |
http://enterabio.com/role/IntangibleAssetsDetails |
| 358 |
Disclosure of detailed information about intangible assets [table] |
Table |
* |
* |
ifrs-full:DisclosureOfIntangibleAssetsTable |
| 359 |
Joint ventures [axis] |
Axis |
|
|
ifrs-full:JointVenturesAxis |
| 360 |
Entity's total for joint ventures [member] |
Member |
|
|
ifrs-full:EntitysTotalForJointVenturesMember |
| 361 |
D.N.A. and Oramed [Member] |
Member |
|
|
entx:DNAandOramedMember |
| 362 |
D.N.A. Biomedical Solutions Ltd. [Member] |
Member |
|
|
entx:DNABiomedicalSolutionsLtdMember |
| 363 |
Oramed [Member] |
Member |
|
|
entx:OramedMember |
| 364 |
Classes of share capital [axis] |
Axis |
|
|
ifrs-full:ClassesOfShareCapitalAxis |
| 365 |
Share capital [member] |
Member |
|
|
ifrs-full:ClassesOfShareCapitalMember |
| 366 |
Preference Shares Series B [Member] |
Member |
|
|
entx:PreferenceSharesSeriesBMember |
| 367 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
| 368 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
| 369 |
Bottom of range [Member] |
Member |
|
|
ifrs-full:BottomOfRangeMember |
| 370 |
Top of range [Member] |
Member |
|
|
ifrs-full:TopOfRangeMember |
| 371 |
Disclosure of detailed information about intangible assets [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfIntangibleAssetsLineItems |
| 372 |
Percentage of ordinary shares |
Concept (Percent) |
For Period |
|
ifrs-full:ProportionOfOwnershipInterestInJointVenture |
| 373 |
Amount invested in joint venture |
Concept (Monetary) |
For Period |
Debit |
entx:ProportionOfAmountInvestedInJointVenture |
| 374 |
Percentage of royalties to be paid |
Concept (Percent) |
As Of |
|
entx:PercentageOfRoyaltiesToBePaid |
| 375 |
Price per share |
Concept (Share) |
As Of |
|
ifrs-full:ParValuePerShare |
| 376 |
Percentage of weighted average cost of capital |
Concept (Percent) |
For Period |
|
ifrs-full:WeightedAverageCostOfCapitalSignificantUnobservableInputsLiabilities |
| 377 |
Commencement of sales years |
Concept (Text/String) |
For Period |
|
entx:DescriptionOfCommencementOfSalesYears |
| 378 |
Percentage of probability of reaching sales |
Concept (Percent) |
For Period |
|
ifrs-full:PercentageOfEntitysRevenue |
| 379 |
00000039 - Disclosure - CONVERTIBLE LOANS (Narrative) (Details) |
Network |
* |
* |
http://enterabio.com/role/ConvertibleLoansNarrativeDetails |
| 380 |
Disclosure of detailed information about borrowings [table] |
Table |
* |
* |
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsTable |
| 381 |
Borrowings by name [axis] |
Axis |
|
|
ifrs-full:BorrowingsByNameAxis |
| 382 |
Borrowings by name [member] |
Member |
|
|
ifrs-full:BorrowingsByNameMember |
| 383 |
2012 Convertible Loan [Member] |
Member |
|
|
entx:ConvertibleLoan2012Member |
| 384 |
2015 Convertible Loan [Member] |
Member |
|
|
entx:ConvertibleLoan2015Member |
| 385 |
Converted to 2016 Loans [Member] |
Member |
|
|
entx:NewConvertibleLoan2016Member |
| 386 |
2016 Convertible Loan [Member] |
Member |
|
|
entx:ConvertibleLoan2016Member |
| 387 |
Joint ventures [axis] |
Axis |
|
|
ifrs-full:JointVenturesAxis |
| 388 |
Entity's total for joint ventures [member] |
Member |
|
|
ifrs-full:EntitysTotalForJointVenturesMember |
| 389 |
D.N.A [Member] |
Member |
|
|
entx:DNAMember |
| 390 |
Disclosure of detailed information about borrowings [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsLineItems |
| 391 |
Borrowings |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Borrowings |
| 392 |
Interest rate |
Concept (Percent) |
As Of |
|
ifrs-full:BorrowingsInterestRate |
| 393 |
Maturity |
Concept (Text/String) |
For Period |
|
ifrs-full:BorrowingsMaturity |
| 394 |
Conversion price per share |
Concept (Share) |
For Period |
|
entx:ConversionPricePerShare |
| 395 |
Convertible loan converted into ordinary shares |
Concept (Shares) |
For Period |
|
entx:ConvertibleLoanConvertedIntoOrdinaryShares |
| 396 |
Number of ordinary shares exchanged |
Concept (Shares) |
For Period |
|
entx:NumberOfOrdinarySharesExchanged |
| 397 |
Number of stock merged |
Concept (Shares) |
For Period |
|
entx:NumberOfStockMerged |
| 398 |
Discount to the applicable price per share in the triggering event |
Concept (Percent) |
As Of |
|
ifrs-full:DescriptionOfDiscountRatesUsedInCurrentEstimateOfValueInUse |
| 399 |
Percentage of warrants to purchase additional shares on conversion |
Concept (Percent) |
For Period |
|
entx:PercentageOfWarrantsToPurchaseAdditionalSharesOnConversion |
| 400 |
Finance expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:FinanceCosts |
| 401 |
Repayments of borrowings |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RepaymentsOfNoncurrentBorrowings |
| 402 |
Deposit amount at trustee |
Concept (Monetary) |
As Of |
Debit |
entx:DepositAmountAtTrustee |
| 403 |
Description of automatically converted loan to shares |
Concept (Text/String) |
For Period |
|
entx:DescriptionOfAutomaticallyConvertedLoanToShares |
| 404 |
Exercisable period of warrants |
Concept (Text/String) |
For Period |
|
entx:DescriptionOfExercisablePeriodOfWarrants |
| 405 |
Transaction expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ShareIssueRelatedCost |
| 406 |
Amount payable in shares |
Concept (Monetary) |
For Period |
Debit |
entx:AmountPayableInShares |
| 407 |
Convertible loan and accrued interest converted into series B-1 preferred shares |
Concept (Shares) |
For Period |
|
entx:ConvertibleLoanAndAccruedInterestConvertedIntoSeriesB1PreferredShares |
| 408 |
Exercise price of warrants |
Concept (Share) |
For Period |
|
entx:ExercisePriceOfWarrants |
| 409 |
Stock split |
Concept (Text/String) |
For Period |
|
entx:StockSplit |
| 410 |
Conversion of convertible loan into Ordinary shares |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments |
| 411 |
00000040 - Disclosure - CONVERTIBLE LOANS (Schedule of Convertible Components) (Details) |
Network |
* |
* |
http://enterabio.com/role/ConvertibleLoansScheduleOfConvertibleComponentsDetails |
| 412 |
Disclosure of detailed information about borrowings [table] |
Table |
* |
* |
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsTable |
| 413 |
Liabilities arising from financing activities [axis] |
Axis |
|
|
ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis |
| 414 |
Liabilities arising from financing activities [member] |
Member |
|
|
ifrs-full:LiabilitiesArisingFromFinancingActivitiesMember |
| 415 |
Convertible loans [Member] |
Member |
|
|
ifrs-full:LongtermBorrowingsMember |
| 416 |
Disclosure of detailed information about borrowings [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsLineItems |
| 417 |
Price per share |
Concept (Share) |
As Of |
|
entx:PricePerShare |
| 418 |
Volatility |
Concept (Percent) |
As Of |
|
entx:DescriptionOfExpectedVolatilityOfConvertibleLoans |
| 419 |
Probability of entering Phase 2b/3 |
Concept (Percent) |
As Of |
|
entx:ProbabilityOfEnteringPhase2b3 |
| 420 |
Probability for IPO |
Concept (Percent) |
As Of |
|
entx:ProbabilityForIPO |
| 421 |
00000041 - Disclosure - CONVERTIBLE LOANS (Schedule of Convertible Loans) (Details) |
Network |
* |
* |
http://enterabio.com/role/ConvertibleLoansScheduleOfConvertibleLoansDetails |
| 422 |
Disclosure of detailed information about borrowings [table] |
Table |
* |
* |
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsTable |
| 423 |
Liabilities arising from financing activities [axis] |
Axis |
|
|
ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis |
| 424 |
Liabilities arising from financing activities [member] |
Member |
|
|
ifrs-full:LiabilitiesArisingFromFinancingActivitiesMember |
| 425 |
Convertible loans [Member] |
Member |
|
|
ifrs-full:LongtermBorrowingsMember |
| 426 |
Warrants to purchase preferred shares and shares [Member] |
Member |
|
|
entx:WarrantsToPurchasePreferredSharesAndSharesMember |
| 427 |
Levels Of Fair Value Hierarchy [Axis] |
Axis |
|
|
ifrs-full:LevelsOfFairValueHierarchyAxis |
| 428 |
All levels of fair value hierarchy [member] |
Member |
|
|
ifrs-full:AllLevelsOfFairValueHierarchyMember |
| 429 |
Level 3 [Member] |
Member |
|
|
ifrs-full:Level3OfFairValueHierarchyMember |
| 430 |
Disclosure of detailed information about borrowings [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsLineItems |
| 431 |
Balance |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:LongtermBorrowings |
| 432 |
Additions |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromNoncurrentBorrowings |
| 433 |
Maturity during period |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RepaymentsOfNoncurrentBorrowings |
| 434 |
Conversion to Series B-1 preferred shares |
Concept (Monetary) |
For Period |
Credit |
entx:ConversionToSeriesBOnePreferredShares |
| 435 |
Financial expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:FinanceCosts |
| 436 |
Changes in fair value |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ChangesInFairValueOfLoansOrReceivablesAttributableToChangesInCreditRiskOfFinancialAssets |
| 437 |
Changes in fair value up to IPO |
Concept (Monetary) |
For Period |
Debit |
entx:ChangesInFairValueOfLoansOrReceivablesAttributableToChangesInCreditRiskOfFinancialAssetsUpToInitialPublicOffering |
| 438 |
Conversion into Ordinary shares on IPO (see Note 10b) |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments |
| 439 |
Conversion to warrants to purchase Series B preferred shares |
Concept (Monetary) |
For Period |
Credit |
entx:ConversionToWarrantsToPurchaseSeriesBPreferredShares |
| 440 |
Balance |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:LongtermBorrowings |
| 441 |
00000042 - Disclosure - PREFERRED SHARES AND WARRANTS TO PREFERED SHARES (Narrative) (Details) |
Network |
* |
* |
http://enterabio.com/role/PreferredSharesAndWarrantsToPreferedSharesNarrativeDetails |
| 442 |
Disclosure of classes of share capital [table] |
Table |
* |
* |
ifrs-full:DisclosureOfClassesOfShareCapitalTable |
| 443 |
Classes of share capital [axis] |
Axis |
|
|
ifrs-full:ClassesOfShareCapitalAxis |
| 444 |
Share capital [member] |
Member |
|
|
ifrs-full:ClassesOfShareCapitalMember |
| 445 |
Centillion preferred share purchase agreement [Member] |
Member |
|
|
entx:CentillionPreferredSharePurchaseAgreementMember |
| 446 |
Additional Centillion preferred share purchase agreement [Member] |
Member |
|
|
entx:AdditionalCentillionPreferredSharePurchaseAgreementMember |
| 447 |
Second amendment to Centillion preferred share purchase agreement [Member] |
Member |
|
|
entx:SecondAmendmentToCentillionPreferredSharePurchaseAgreementMember |
| 448 |
Preferred Shares Series B- 1 [Member] |
Member |
|
|
entx:PreferenceSharesSeriesB1Member |
| 449 |
Series A preferred shares [Member] |
Member |
|
|
entx:SeriesAPreferredSharesMember |
| 450 |
Series B preferred shares [Member] |
Member |
|
|
entx:SeriesBPreferredSharesMember |
| 451 |
Warrants [Member] |
Member |
|
|
entx:WarrantsMember |
| 452 |
Separate management entities [axis] |
Axis |
|
|
ifrs-full:SeparateManagementEntitiesAxis |
| 453 |
Separate management entities [member] |
Member |
|
|
ifrs-full:SeparateManagementEntitiesMember |
| 454 |
Investors [Member] |
Member |
|
|
entx:InvestorsMember |
| 455 |
Broker dealer [Member] |
Member |
|
|
entx:BrokerDealerMember |
| 456 |
Mr. Luke Beshar [Member] |
Member |
|
|
entx:LukeBesharMember |
| 457 |
Dr. Graceau [Member] |
Member |
|
|
entx:RogerGraceauMember |
| 458 |
Borrowings by name [axis] |
Axis |
|
|
ifrs-full:BorrowingsByNameAxis |
| 459 |
Borrowings by name [member] |
Member |
|
|
ifrs-full:BorrowingsByNameMember |
| 460 |
2016 Convertible Loan [Member] |
Member |
|
|
entx:ConvertibleLoan2016Member |
| 461 |
Categories of related parties [axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
| 462 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
| 463 |
Related parties [member] |
Member |
|
|
ifrs-full:RelatedPartiesMember |
| 464 |
Disclosure of classes of share capital [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalLineItems |
| 465 |
Number of preferred shares purchased |
Concept (Shares) |
For Period |
|
entx:NumberOfPreferredSharesPurchased |
| 466 |
Number of preferred shares purchased, value |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromIssueOfPreferenceShares |
| 467 |
Number of preferred shares purchased, price per share |
Concept (Share) |
For Period |
|
entx:NumberOfPreferredSharesPurchasedPricePerShare |
| 468 |
Warrants issued to purchase shares |
Concept (Shares) |
For Period |
|
entx:WarrantsIssuedToPurchaseShares |
| 469 |
Fair value of preferred shares |
Concept (Monetary) |
For Period |
Credit |
entx:FairValueOfPreferredShares |
| 470 |
Fair value of warrants |
Concept (Monetary) |
For Period |
Debit |
entx:FairValueOfWarrants |
| 471 |
Percentage of discount applicable to price per share |
Concept (Percent) |
For Period |
|
entx:PercentageOfDiscountApplicableToPricePerShare |
| 472 |
Number of warrants converted into additional warrants to purchase ordinary shares |
Concept (Shares) |
For Period |
|
entx:NumberOfWarrantsConvertedIntoAdditionalWarrantsToPurchaseOrdinaryShares |
| 473 |
Value of additional warrants issued |
Concept (Monetary) |
For Period |
Credit |
entx:ValueOfAdditionalWarrantsIssued |
| 474 |
Exercise price of warrants |
Concept (Share) |
For Period |
|
entx:ExercisePriceOfWarrants |
| 475 |
Total consideration net of issuance costs |
Concept (Monetary) |
For Period |
Debit |
entx:NetProceedsFromIssueOfPreferenceShares |
| 476 |
Additional issuance costs |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ShareIssueRelatedCost |
| 477 |
Shares issued in conversion of debt |
Concept (Shares) |
For Period |
|
entx:SharesIssuedInConversionOfDebt |
| 478 |
Number of preferred shares converted to ordinary shares following closing of IPO |
Concept (Shares) |
For Period |
|
entx:NumberOfPreferredSharesConvertedToOrdinarySharesFollowingClosingOfInitialPublicOfferring |
| 479 |
Shares issued in conversion of debt, value |
Concept (Monetary) |
For Period |
Credit |
entx:SharesIssuedInConversionOfDebtValue |
| 480 |
Shares issued in conversion of debt, price per share |
Concept (Share) |
For Period |
|
entx:SharesIssuedInConversionOfDebtPricePerShare |
| 481 |
Options granted to purchase ordinary shares |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement |
| 482 |
Interest rate on preferred shares |
Concept (Percent) |
For Period |
|
entx:InterestRateOnPreferredShares |
| 483 |
Conversion into ordinary shares |
Concept (Shares) |
For Period |
|
entx:ConversionIntoOrdinaryShares |
| 484 |
Warrant term |
Concept (Text/String) |
For Period |
|
entx:WarrantTerm |
| 485 |
Effective price per share |
Concept (Share) |
For Period |
|
entx:EffectivePricePerShare |
| 486 |
Exceeds sales price per share |
Concept (Share) |
For Period |
|
entx:ExceedsSalesPricePerShare |
| 487 |
Percentage of per unit price |
Concept (Percent) |
For Period |
|
entx:PercentageOfPerUnitPrice |
| 488 |
00000043 - Disclosure - PREFERRED SHARES AND WARRANTS TO PREFERED SHARES (Schedule of Movements in Three Components) (Details) |
Network |
* |
* |
http://enterabio.com/role/PreferredSharesAndWarrantsToPreferedSharesScheduleOfMovementsInThreeComponentsDetails |
| 489 |
Disclosure of classes of share capital [table] |
Table |
* |
* |
ifrs-full:DisclosureOfClassesOfShareCapitalTable |
| 490 |
Classes of share capital [axis] |
Axis |
|
|
ifrs-full:ClassesOfShareCapitalAxis |
| 491 |
Share capital [member] |
Member |
|
|
ifrs-full:ClassesOfShareCapitalMember |
| 492 |
Preferred shares [Member] |
Member |
|
|
ifrs-full:PreferenceSharesMember |
| 493 |
Warrants to purchase preferred shares and shares [Member] |
Member |
|
|
entx:WarrantsToPurchasePreferredSharesAndSharesMember |
| 494 |
Liability to issue preferred shares and warrants [Member] |
Member |
|
|
entx:LiabilityToIssuePreferredSharesAndWarrantsMember |
| 495 |
Disclosure of classes of share capital [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalLineItems |
| 496 |
Balance |
Concept (Monetary) |
As Of |
Credit |
entx:PreferredSharesAndWarrantsToPreferedShares |
| 497 |
Issuance of Series B preferred shares and warrants to purchase Series B preferred shares |
Concept (Monetary) |
For Period |
Credit |
entx:IssuanceOfSeriesBPreferredSharesAndWarrantsToPurchaseSeriesBPreferredShares |
| 498 |
Conversion of 2016 Convertible Loan and warrants to series B-1 preferred shares and warrant to purchase Series B preferred shares |
Concept (Monetary) |
For Period |
Credit |
entx:ConversionOf2016ConvertibleLoanAndWarrantsToSeriesB1PreferredSharesAndWarrantToPurchaseSeriesBPreferredShares |
| 499 |
Change of conditions of the liability to issue preferred shares and warrants to warrants |
Concept (Monetary) |
For Period |
Credit |
entx:ChangeOfConditionsOfLiabilityToIssuePreferredSharesAndWarrantsToWarrants |
| 500 |
Changes in fair value |
Concept (Monetary) |
For Period |
Credit |
entx:ChangesInFairValueOfPreferredSharesWarrantsToPurchasePreferredSharesAndLiabilityToIssuePreferredSharesAndWarrants |
| 501 |
Conversion of Preferred shares to Ordinary shares on IPO |
Concept (Monetary) |
For Period |
Credit |
entx:ConversionOfPreferredSharesToOrdinarySharesOnIpo |
| 502 |
Conversion of Warrants to purchase preferred shares to Warrants to purchase ordinary shares on IPO |
Concept (Monetary) |
For Period |
Credit |
entx:ConversionOfWarrantsToPurchasePreferredSharesToWarrantsToPurchaseOrdinarySharesOnIpo |
| 503 |
Balance |
Concept (Monetary) |
As Of |
Credit |
entx:PreferredSharesAndWarrantsToPreferedShares |
| 504 |
00000044 - Disclosure - PREFERRED SHARES AND WARRANTS TO PREFERED SHARE (Schedule of Valuations of Fair Value of Instruments) (Details) |
Network |
* |
* |
http://enterabio.com/role/PreferredSharesAndWarrantsToPreferedSharesAndSharesScheduleOfValuationsOfFairValueOfInstrumentsDetails |
| 505 |
Disclosure of fair value measurement of assets [table] |
Table |
* |
* |
ifrs-full:DisclosureOfFairValueMeasurementOfAssetsTable |
| 506 |
Levels Of Fair Value Hierarchy [Axis] |
Axis |
|
|
ifrs-full:LevelsOfFairValueHierarchyAxis |
| 507 |
All levels of fair value hierarchy [member] |
Member |
|
|
ifrs-full:AllLevelsOfFairValueHierarchyMember |
| 508 |
Level 3 [Member] |
Member |
|
|
ifrs-full:Level3OfFairValueHierarchyMember |
| 509 |
Disclosure of fair value measurement of assets [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfFairValueMeasurementOfAssetsLineItems |
| 510 |
Price per share |
Concept (Share) |
As Of |
|
entx:PricePerShare |
| 511 |
Value of equity |
Concept (Monetary) |
As Of |
Credit |
entx:ValueOfEquity |
| 512 |
Volatility |
Concept (Percent) |
As Of |
|
entx:DescriptionOfExpectedVolatilityOfConvertibleLoans |
| 513 |
Probability of entering Phase 2b/3 |
Concept (Percent) |
As Of |
|
entx:ProbabilityOfEnteringPhase2b3 |
| 514 |
Probability for IPO |
Concept (Percent) |
As Of |
|
entx:ProbabilityForIPO |
| 515 |
00000045 - Disclosure - COMMITMENTS (Details) |
Network |
* |
* |
http://enterabio.com/role/CommitmentsDetails |
| 516 |
IfrsStatementsTable [Table] |
Table |
* |
* |
entx:IfrsStatementsTable |
| 517 |
Non-adjusting events after reporting period [Axis] |
Axis |
|
|
ifrs-full:NonadjustingEventsAfterReportingPeriodAxis |
| 518 |
Non-adjusting events after reporting period [member] |
Member |
|
|
ifrs-full:NonadjustingEventsMember |
| 519 |
Amgen Inc [Member] |
Member |
|
|
entx:AmgenIncMember |
| 520 |
Statement Line Items [Line Items] |
LineItems |
|
|
entx:IfrsStatementLineItems |
| 521 |
Lease expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:LeaseAndSubleasePaymentsRecognisedAsExpense |
| 522 |
Lease expiration period |
Concept (Text/String) |
For Period |
|
ifrs-full:DescriptionOfMaterialLeasingArrangementsByLesseeClassifiedAsOperatingLease |
| 523 |
Percentage of royalty payable on sales of products developed during first three years |
Concept (Percent) |
For Period |
|
entx:PercentageOfRoyaltyPayableOnSalesOfProductsDevelopedDuringFirstThreeYears |
| 524 |
Percentage of royalty payable on sales of products developed during subsequent three years |
Concept (Percent) |
For Period |
|
entx:PercentageOfRoyaltyPayableOnSalesOfProductsDevelopedDuringSubsequentThreeYears |
| 525 |
Percentage of royalty payable on sales of products developed during commencing of seventh year |
Concept (Percent) |
For Period |
|
entx:PercentageOfRoyaltyPayableOnSalesOfProductsDevelopedDuringCommencingOfSeventhYear |
| 526 |
Percentage of royalty payable on grants received by company |
Concept (Percent) |
For Period |
|
entx:PercentageOfRoyaltyPayableOnGrantsReceivedByCompany |
| 527 |
Royalty amount payable |
Concept (Monetary) |
As Of |
Credit |
entx:RoyaltyAmountPayable |
| 528 |
Percentage to be paid for each payment received |
Concept (Percent) |
For Period |
|
entx:PercentageOfEachPaymentReceived |
| 529 |
Amount paid to government of israel |
Concept (Monetary) |
For Period |
Credit |
entx:AmountPaidToGovernmentOfIsrael |
| 530 |
00000046 - Disclosure - SHARE CAPITAL (Narrative) (Details) |
Network |
* |
* |
http://enterabio.com/role/ShareCapitalNarrativeDetails |
| 531 |
Disclosure of classes of share capital [table] |
Table |
* |
* |
ifrs-full:DisclosureOfClassesOfShareCapitalTable |
| 532 |
Classes of share capital [axis] |
Axis |
|
|
ifrs-full:ClassesOfShareCapitalAxis |
| 533 |
Share capital [member] |
Member |
|
|
ifrs-full:ClassesOfShareCapitalMember |
| 534 |
IPO [Member] |
Member |
|
|
entx:InitialPublicOfferingMember |
| 535 |
Warrants [Member] |
Member |
|
|
entx:WarrantsMember |
| 536 |
Ordinary shares [member] |
Member |
|
|
ifrs-full:OrdinarySharesMember |
| 537 |
Series A preferred shares [Member] |
Member |
|
|
entx:SeriesAPreferredSharesMember |
| 538 |
Series B preferred shares [Member] |
Member |
|
|
entx:SeriesBPreferredSharesMember |
| 539 |
Series B-1 preferred shares [Member] |
Member |
|
|
entx:SeriesB1PreferredSharesMember |
| 540 |
Warrants to series A preferred shares [Member] |
Member |
|
|
entx:WarrantsToSeriesAPreferredSharesMember |
| 541 |
Warrants to series B preferred shares [Member] |
Member |
|
|
entx:WarrantsToSeriesBPreferredSharesMember |
| 542 |
Warrants to series B-1 preferred shares [Member] |
Member |
|
|
entx:WarrantsToSeriesB1PreferredSharesMember |
| 543 |
Borrowings by name [axis] |
Axis |
|
|
ifrs-full:BorrowingsByNameAxis |
| 544 |
Borrowings by name [member] |
Member |
|
|
ifrs-full:BorrowingsByNameMember |
| 545 |
2012 Convertible Loan [Member] |
Member |
|
|
entx:ConvertibleLoan2012Member |
| 546 |
Separate management entities [axis] |
Axis |
|
|
ifrs-full:SeparateManagementEntitiesAxis |
| 547 |
Separate management entities [member] |
Member |
|
|
ifrs-full:SeparateManagementEntitiesMember |
| 548 |
Investors [Member] |
Member |
|
|
entx:InvestorsMember |
| 549 |
Underwriters [Member] |
Member |
|
|
entx:UnderwritersMember |
| 550 |
Mr. Luke Beshar [Member] |
Member |
|
|
entx:LukeBesharMember |
| 551 |
Dr. Graceau [Member] |
Member |
|
|
entx:RogerGraceauMember |
| 552 |
Dr. Eric Lang [Member] |
Member |
|
|
entx:DrEricLangMember |
| 553 |
Types of share-based payment arrangements [axis] |
Axis |
|
|
ifrs-full:TypesOfSharebasedPaymentArrangementsAxis |
| 554 |
Share-based payment arrangements [member] |
Member |
|
|
ifrs-full:SharebasedPaymentArrangementsMember |
| 555 |
Certain Consultant [Member] |
Member |
|
|
entx:CertainConsultantMember |
| 556 |
Certain Director [Member] |
Member |
|
|
entx:CertainDirectorMember |
| 557 |
CEO, COO and CFO [Member] |
Member |
|
|
entx:ChiefExecutiveOfficerChiefOperatingOfficerAndChiefFinancialOfficerMember |
| 558 |
Certain Employees [Member] |
Member |
|
|
entx:CertainEmployeesMember |
| 559 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
| 560 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
| 561 |
Bottom of range [Member] |
Member |
|
|
ifrs-full:BottomOfRangeMember |
| 562 |
Top of range [Member] |
Member |
|
|
ifrs-full:TopOfRangeMember |
| 563 |
Disclosure of classes of share capital [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalLineItems |
| 564 |
Stock split |
Concept (Text/String) |
For Period |
|
entx:StockSplit |
| 565 |
Number of shares issued |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesIssued |
| 566 |
Warrants issued to purchase shares |
Concept (Shares) |
For Period |
|
entx:WarrantsIssuedToPurchaseShares |
| 567 |
Warrants converted into ordinary shares |
Concept (Shares) |
For Period |
|
entx:WarrantsConvertedIntoOrdinaryShares |
| 568 |
Proceeds from issuance of ordinary shares, net |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromIssueOfOrdinaryShares |
| 569 |
Proceeds from issuance of ordinary shares, gross |
Concept (Monetary) |
For Period |
Debit |
entx:ProceedsFromIssueOfOrdinarySharesGross |
| 570 |
Stock issuance costs |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ShareIssueRelatedCost |
| 571 |
Underwriters fee |
Concept (Monetary) |
For Period |
Debit |
entx:UnderwritersFee |
| 572 |
Other issuance costs |
Concept (Monetary) |
For Period |
Debit |
entx:OtherIssuanceCosts |
| 573 |
Exercise price of warrants |
Concept (Share) |
For Period |
|
entx:ExercisePriceOfWarrants |
| 574 |
Public offering price per unit |
Concept (Share) |
For Period |
|
entx:PublicOfferingPricePerUnit |
| 575 |
Number of ordinary shares that can be purchased through each tradeable warrant |
Concept (Shares) |
For Period |
|
entx:NumberOfOrdinarySharesThatCanBePurchasedThroughEachTradeableWarrant |
| 576 |
Convertible loan converted into ordinary shares |
Concept (Shares) |
For Period |
|
entx:ConvertibleLoanConvertedIntoOrdinaryShares |
| 577 |
Conversion into ordinary shares |
Concept (Shares) |
For Period |
|
entx:ConversionIntoOrdinaryShares |
| 578 |
Par value per share |
Concept (Share) |
As Of |
|
ifrs-full:ParValuePerShare |
| 579 |
Options granted to purchase ordinary shares |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement |
| 580 |
Warrants granted to purchase ordinary shares |
Concept (Shares) |
For Period |
|
entx:WarrantsGrantedToPurchaseOrdinaryShares |
| 581 |
Exercise price |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement |
| 582 |
Options vesting description |
Concept (Text/String) |
For Period |
|
ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement |
| 583 |
Fair value of options |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted |
| 584 |
Fair value of warrants |
Concept (Monetary) |
For Period |
Debit |
entx:FairValueOfWarrants |
| 585 |
Remaining unrecognized compensation expense |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees |
| 586 |
Percentage of options granted to purchase ordinary shares |
Concept (Percent) |
For Period |
|
entx:PercentageOfOptionsGrantedToPurchaseOrdinaryShares |
| 587 |
Amount of new funds to be received by Company upon triggering event |
Concept (Monetary) |
For Period |
Credit |
entx:AmountOfNewFundsToBeReceivedUponTriggeringEvent |
| 588 |
Reserved ordinary shares |
Concept (Shares) |
For Period |
|
entx:ReservedOrdinaryShares |
| 589 |
Option forfeited |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement |
| 590 |
Reversal of expense recognized in General and Administrative expense due to forfeiture of options |
Concept (Monetary) |
For Period |
Credit |
entx:ReversalOfExpenseForForfeitureOfOptionsToBoardOfDirectors |
| 591 |
Intrinsic value |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:IntrinsicValueOfLiabilitiesFromSharebasedPaymentTransactionsForWhichCounterpartysRightToCashOrOtherAssetsVested2011 |
| 592 |
00000047 - Disclosure - SHARE CAPITAL (Schedule of Composed of Ordinary Shares) (Details) |
Network |
* |
* |
http://enterabio.com/role/ShareCapitalScheduleOfComposedOfOrdinarySharesDetails |
| 593 |
Implied Table |
Table |
* |
* |
implied:Table |
| 594 |
Disclosure of classes of share capital [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalAbstract |
| 595 |
Authorized |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesAuthorised |
| 596 |
Issued |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesIssued |
| 597 |
Par value per share |
Concept (Share) |
As Of |
|
ifrs-full:ParValuePerShare |
| 598 |
00000048 - Disclosure - SHARE CAPITAL (Schedule of Weighted Average Assumptions) (Details) |
Network |
* |
* |
http://enterabio.com/role/ShareCapitalScheduleOfWeightedAverageAssumptionsDetails |
| 599 |
Implied Table |
Table |
* |
* |
implied:Table |
| 600 |
Disclosure of classes of share capital [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalAbstract |
| 601 |
Par value per share |
Concept (Share) |
As Of |
|
ifrs-full:ParValuePerShare |
| 602 |
Ordinary share price |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageSharePriceShareOptionsGranted |
| 603 |
Exercise price |
Concept (Monetary) |
For Period |
|
ifrs-full:ExercisePriceShareOptionsGranted |
| 604 |
Dividend yield |
Concept (Percent) |
For Period |
|
ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted |
| 605 |
Expected volatility |
Concept (Percent) |
For Period |
|
ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted |
| 606 |
Risk-free interest rate |
Concept (Percent) |
For Period |
|
ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted |
| 607 |
Expected life - in years |
Concept (Decimal) |
For Period |
|
ifrs-full:DescriptionOfOptionLifeShareOptionsGranted |
| 608 |
00000049 - Disclosure - SHARE CAPITAL (Schedule of Changes in Number of Options and Weighted Average Exercise Prices) (Details) |
Network |
* |
* |
http://enterabio.com/role/ShareCapitalScheduleOfChangesInNumberOfOptionsAndWeightedAverageExercisePricesDetails |
| 609 |
Implied Table |
Table |
* |
* |
implied:Table |
| 610 |
Disclosure of classes of share capital [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalAbstract |
| 611 |
Number of options |
Abstract |
|
|
entx:NumberOfOutstandingShareOptionsAbstract |
| 612 |
Outstanding at beginning of year |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfOutstandingShareOptions |
| 613 |
Forfeited |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement |
| 614 |
Exercised |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement |
| 615 |
Granted |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement |
| 616 |
Outstanding at end of year |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfOutstandingShareOptions |
| 617 |
Exercisable at end of year |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement |
| 618 |
Weighted average exercise price |
Abstract |
|
|
entx:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangementAbstract |
| 619 |
Outstanding at beginning of year |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement |
| 620 |
Forfeited |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement |
| 621 |
Exercised |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement |
| 622 |
Granted |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement |
| 623 |
Outstanding at end of year |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement |
| 624 |
Exercisable at end of year |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement |
| 625 |
Intrinsic value |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:IntrinsicValueOfLiabilitiesFromSharebasedPaymentTransactionsForWhichCounterpartysRightToCashOrOtherAssetsVested2011 |
| 626 |
00000050 - Disclosure - SHARE CAPITAL (Schedule of Information about Exercise Price and Remaining Contractual Life of Outstanding Options) (Details) |
Network |
* |
* |
http://enterabio.com/role/ShareCapitalScheduleOfInformationAboutExercisePriceAndRemainingContractualLifeOfOutstandingOptionsDetails |
| 627 |
Disclosure of number and weighted average remaining contractual life of outstanding share options [table] |
Table |
* |
* |
ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable |
| 628 |
Ranges of exercise prices for outstanding share options [axis] |
Axis |
|
|
ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis |
| 629 |
Ranges of exercise prices for outstanding share options [member] |
Member |
|
|
ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsMember |
| 630 |
Exercise Price One [Member] |
Member |
|
|
entx:ExercisePriceOneMember |
| 631 |
Exercise Price Two [Member] |
Member |
|
|
entx:ExercisePriceTwoMember |
| 632 |
Exercise Price Three [Member] |
Member |
|
|
entx:ExercisePriceThreeMember |
| 633 |
Exercise Price Four [Member] |
Member |
|
|
entx:ExercisePriceFourMember |
| 634 |
Exercise Price Five [Member] |
Member |
|
|
entx:ExercisePriceFiveMember |
| 635 |
Exercise Price Six [Member] |
Member |
|
|
entx:ExercisePriceSixMember |
| 636 |
Exercise Price Seven [Member] |
Member |
|
|
entx:ExercisePriceSevenMember |
| 637 |
Exercise Price Eight [Member] |
Member |
|
|
entx:ExercisePriceEightMember |
| 638 |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems |
| 639 |
Number of options outstanding at end of year |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfOutstandingShareOptions |
| 640 |
Exercise price |
Concept (Monetary) |
As Of |
|
ifrs-full:ExercisePriceOfOutstandingShareOptions |
| 641 |
Weighted average of remaining contractual life |
Concept (Decimal) |
As Of |
|
ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions |
| 642 |
00000051 - Disclosure - TAXES ON INCOME (Details) |
Network |
* |
* |
http://enterabio.com/role/TaxesOnIncomeDetails |
| 643 |
Implied Table |
Table |
* |
* |
implied:Table |
| 644 |
Major components of tax expense (income) [abstract] |
Abstract |
|
|
ifrs-full:MajorComponentsOfTaxExpenseIncomeAbstract |
| 645 |
Israel corporate tax rates |
Concept (Percent) |
For Period |
|
ifrs-full:ApplicableTaxRate |
| 646 |
Reduction in tax rate |
Concept (Text/String) |
For Period |
|
ifrs-full:ExplanationOfChangesInApplicableTaxRatesToPreviousAccountingPeriod |
| 647 |
Carryforward losses |
Concept (Monetary) |
As Of |
Debit |
entx:CarryforwardLosses |
| 648 |
Income tax rate in United states |
Concept (Percent) |
For Period |
|
entx:IncomeTaxRate |
| 649 |
00000052 - Disclosure - REVENUE FROM CONTRACTS WITH CUSTOMERS (Schedule of Revenues) (Details) |
Network |
* |
* |
http://enterabio.com/role/RevenueFromContractsWithCustomersScheduleOfRevenuesDetails |
| 650 |
Implied Table |
Table |
* |
* |
implied:Table |
| 651 |
Receivables from contracts with customers [abstract] |
Abstract |
|
|
ifrs-full:ReceivablesFromContractsWithCustomersAbstract |
| 652 |
Revenues from license |
Concept (Monetary) |
For Period |
Credit |
entx:RevenueFromLicense |
| 653 |
Revenues from preclinical research and development |
Concept (Monetary) |
For Period |
Credit |
entx:RevenuesFromPreclinicalResearchAndDevelopment |
| 654 |
Total revenues |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:Revenue |
| 655 |
Contract liability |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:ContractLiabilities |
| 656 |
00000053 - Disclosure - SUPPLEMENTARY FINANCIAL INFORMATION (Schedule of Other Current Assets) (Details) |
Network |
* |
* |
http://enterabio.com/role/SupplementaryFinancialInformationScheduleOfOtherCurrentAssetsDetails |
| 657 |
Implied Table |
Table |
* |
* |
implied:Table |
| 658 |
Disclosure of supplementary financial information [abstract] |
Abstract |
|
|
entx:DisclosureOfSupplementaryFinancialInformationAbstract |
| 659 |
Other current assets: |
Abstract |
|
|
ifrs-full:CurrentAssetsAbstract |
| 660 |
Prepaid expenses |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentPrepaidExpenses |
| 661 |
Restricted deposits |
Concept (Monetary) |
As Of |
Debit |
entx:OtherCurrentRestrictedDeposits |
| 662 |
Other |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:OtherCurrentAssets |
| 663 |
Other current assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:OtherCurrentFinancialAssets |
| 664 |
00000054 - Disclosure - SUPPLEMENTARY FINANCIAL INFORMATION (Schedule of Accounts Payable Other) (Details) |
Network |
* |
* |
http://enterabio.com/role/SupplementaryFinancialInformationScheduleOfAccountsPayableOtherDetails |
| 665 |
Implied Table |
Table |
* |
* |
implied:Table |
| 666 |
Disclosure of supplementary financial information [abstract] |
Abstract |
|
|
entx:DisclosureOfSupplementaryFinancialInformationAbstract |
| 667 |
Accounts payable - other: |
Abstract |
|
|
ifrs-full:TradeAndOtherCurrentPayablesAbstract |
| 668 |
Employees and employees related |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:ShorttermEmployeeBenefitsAccruals |
| 669 |
Provision for vacation |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentProvisions |
| 670 |
Accrued expenses and other |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities |
| 671 |
Accounts payable - other |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:TradeAndOtherCurrentPayables |
| 672 |
00000055 - Disclosure - BASIC AND DILUTED LOSS PER SHARE (Narrative) (Details) |
Network |
* |
* |
http://enterabio.com/role/BasicAndDilutedLossPerShareNarrativeDetails |
| 673 |
Disclosure of classes of share capital [table] |
Table |
* |
* |
ifrs-full:DisclosureOfClassesOfShareCapitalTable |
| 674 |
Borrowings by name [axis] |
Axis |
|
|
ifrs-full:BorrowingsByNameAxis |
| 675 |
Borrowings by name [member] |
Member |
|
|
ifrs-full:BorrowingsByNameMember |
| 676 |
2012 Convertible Loan, 2016 Convertible Loan, preferred shares and warrants [Member] |
Member |
|
|
entx:ConvertibleLoan2012ConvertibleLoan2016PreferredSharesAndWarrantsMember |
| 677 |
Disclosure of classes of share capital [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalLineItems |
| 678 |
Number of ordinary shares related to the outstanding options excluded from the calculation of diluted loss per share |
Concept (Shares) |
For Period |
|
ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares |
| 679 |
00000056 - Disclosure - BASIC AND DILUTED LOSS PER SHARE (Schedule of Basic and Diluted Loss Per Share) (Details) |
Network |
* |
* |
http://enterabio.com/role/BasicAndDilutedLossPerShareScheduleOfBasicAndDilutedLossPerShareDetails |
| 680 |
Implied Table |
Table |
* |
* |
implied:Table |
| 681 |
Basic and diluted earnings per share [abstract] |
Abstract |
|
|
ifrs-full:BasicAndDilutedEarningsPerShareAbstract |
| 682 |
Loss attributable to equity holders of the Company |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ComprehensiveIncome |
| 683 |
Income from change in fair value of financial liabilities at fair value |
Concept (Monetary) |
For Period |
Credit |
entx:IncomeFromChangeInFairValueOfFinancialLiabilitiesAtFairValue |
| 684 |
Loss used for the computation of diluted loss per share |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests |
| 685 |
Weighted average number of Ordinary Shares used in the computation of basic loss per share |
Concept (Shares) |
For Period |
|
ifrs-full:WeightedAverageShares |
| 686 |
Add: Weighted average number of additional shares issuable upon the assumed conversion/exercise of 2012 convertible loan, preferred shares and warrants to issue preferred shares and shares |
Concept (Shares) |
For Period |
|
ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued |
| 687 |
Weighted average number of Ordinary Shares used in the computation of diluted loss per share |
Concept (Shares) |
For Period |
|
ifrs-full:AdjustedWeightedAverageShares |
| 688 |
Basic loss per Ordinary Share |
Concept (Share) |
For Period |
|
ifrs-full:BasicEarningsLossPerShare |
| 689 |
Diluted loss per Ordinary Share |
Concept (Share) |
For Period |
|
ifrs-full:DilutedEarningsLossPerShare |
| 690 |
00000057 - Disclosure - RELATED PARTIES - TRANSACTIONS AND BALANCES (Narrative) (Details) |
Network |
* |
* |
http://enterabio.com/role/RelatedParties-TransactionsAndBalancesNarrativeDetails |
| 691 |
Disclosure of transactions between related parties [table] |
Table |
* |
* |
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesTable |
| 692 |
Categories of related parties [axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
| 693 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
| 694 |
Mr. Luke Beshar [Member] |
Member |
|
|
entx:LukeBesharMember |
| 695 |
Dr. Graceau [Member] |
Member |
|
|
entx:RogerGraceauMember |
| 696 |
Disclosure of transactions between related parties [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesLineItems |
| 697 |
Monthly fee |
Concept (Monetary) |
For Period |
Debit |
entx:KeyManagementPersonnelCompensationMonthlyFee |
| 698 |
Options granted to purchase ordinary shares |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement |
| 699 |
Exercise price |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement |
| 700 |
Options vested |
Concept (Text/String) |
For Period |
|
ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement |
| 701 |
00000058 - Disclosure - RELATED PARTIES - TRANSACTIONS AND BALANCES (Schedule of Transactions with Related Parties) (Details) |
Network |
* |
* |
http://enterabio.com/role/RelatedParties-TransactionsAndBalancesScheduleOfTransactionsWithRelatedPartiesDetails |
| 702 |
Implied Table |
Table |
* |
* |
implied:Table |
| 703 |
Disclosure of transactions between related parties [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesAbstract |
| 704 |
Key management compensation: |
Abstract |
|
|
entx:KeyManagementCompensationAbstract |
| 705 |
Labor cost and related expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits |
| 706 |
Share-based compensation |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment |
| 707 |
Directors fee and services |
Concept (Monetary) |
For Period |
Debit |
entx:KeyManagementPersonnelCompensationDirectorsFeeAndServices |
| 708 |
Others |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:KeyManagementPersonnelCompensationOtherLongtermBenefits |
| 709 |
Key management compensation |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:KeyManagementPersonnelCompensation |
| 710 |
00000059 - Disclosure - RELATED PARTIES - TRANSACTIONS AND BALANCES (Schedule of Balances with Related Parties) (Details) |
Network |
* |
* |
http://enterabio.com/role/RelatedParties-TransactionsAndBalancesScheduleOfBalancesWithRelatedPartiesDetails |
| 711 |
Implied Table |
Table |
* |
* |
implied:Table |
| 712 |
Disclosure of transactions between related parties [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesAbstract |
| 713 |
Key management: |
Abstract |
|
|
ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract |
| 714 |
Payables and accrued expenses |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:AmountsPayableRelatedPartyTransactions |
| 715 |
Severance pay obligations |
Concept (Monetary) |
As Of |
Credit |
entx:SeverancePayObligationsRelatedPartyTransactions |
| 716 |
Provision for vacation |
Concept (Monetary) |
As Of |
Credit |
entx:ProvisionForVacationRelatedPartyTransactions |
| 717 |
Directors fee and services |
Concept (Monetary) |
As Of |
Credit |
entx:DirectorsFeeAndServicesRelatedPartyTransactions |
| 718 |
00000060 - Disclosure - SUBSEQUENT EVENTS (Details) |
Network |
* |
* |
http://enterabio.com/role/SubsequentEventsDetails |
| 719 |
Disclosure of non-adjusting events after reporting period [table] |
Table |
* |
* |
ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodTable |
| 720 |
Categories of related parties [axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
| 721 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
| 722 |
Certain Employees [Member] |
Member |
|
|
entx:CertainEmployeesMember |
| 723 |
CMO [Member] |
Member |
|
|
entx:CmoMember |
| 724 |
Non-executive Directors [Member] |
Member |
|
|
entx:NonExecutiveDirectorsMember |
| 725 |
Disclosure of non-adjusting events after reporting period [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems |
| 726 |
Options granted to purchase ordinary shares |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement |
| 727 |
Exercise price |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement |
| 728 |
Fair value of options |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted |
| 729 |
Options vesting description |
Concept (Text/String) |
For Period |
|
ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement |